Paraganglioma screening: Difference between revisions

Jump to navigation Jump to search
(Created page with "'''For patient information click here''' {{Paraganglioma}} {{CMG}} ==Overview== A '''paraganglioma''' is a rare neoplasm that can...")
 
No edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
'''For patient information click [[Paraganglioma (patient information)|here]]'''
__NOTOC__
 
{{Paraganglioma}}
{{Paraganglioma}}
{{CMG}}


{{CMG}}; {{AE}}
==Overview==
==Overview==
A '''paraganglioma''' is a rare [[neoplasm]] that can be found in the abdomen, thorax, and in the head and neck region.  They are usually considered [[benign]] and complete surgical removal results in cure. However, in about 3% of cases they are [[malignant]] and have the ability to [[metastasis|metastasize]].  Paragangliomas are still sometimes called '''glomus tumors''' (not to be confused with [[glomus tumor]]s of the skin) and '''chemodectomas''', but paraganglioma is the currently accepted and preferred term.
 
There is insufficient evidence to recommend routine screening for [disease/malignancy].
 
OR
 
According to the [guideline name], screening for [disease name] is not recommended.
 
OR
 
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
==Screening==
There is insufficient evidence to recommend routine screening for [disease/malignancy].
 
OR
 
According to the [guideline name], screening for [disease name] is not recommended.
 
OR
 
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
*[Condition 1]
*[Condition 2]
*[Condition 3]


==References==
==References==
{{reflist|2}}
{{Reflist|2}}
{{Epithelial neoplasms}}
 
[[de:Paragangliom]]
[[nl:Paraganglioom]]
[[sk:Paraganglióm]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
{{WH}}
[[Category:Types of cancer]]
{{WS}}
[[Category:Oncology]]
[[Category: (name of the system)]]
[[Category:Mature chapter]]

Latest revision as of 17:43, 31 January 2019

Paraganglioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Paraganglioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT Scan

MRI

Echocardiography and Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Paraganglioma screening On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Paraganglioma screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Paraganglioma screening

CDC on Paraganglioma screening

Paraganglioma screening in the news

Blogs on Paraganglioma screening

Directions to Hospitals Treating Paraganglioma

Risk calculators and risk factors for Paraganglioma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].

Screening

There is insufficient evidence to recommend routine screening for [disease/malignancy].

OR

According to the [guideline name], screening for [disease name] is not recommended.

OR

According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:

  • [Condition 1]
  • [Condition 2]
  • [Condition 3]

References

Template:WH Template:WS